Stock listing
APTX Stock Price, News, Filings & Events — Apotex Health Corp.
Selected listing: APTX · TSX · CAD · CA
This page tracks Apotex Health Corp.'s APTX:TSX listing on TSX in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following APTX:TSX. APTX:TSX is the stock-level entry point for investors researching Apotex Health Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Apotex Health Corp. is a public company listed under the ticker APTX, operating in the Canadian market. The company has a market capitalization of approximately CAD 5.83 billion. Apotex focuses on providing healthcare solutions and is recognized for its commitment to improving patient outcomes.
- Ticker
- APTX:TSX
- Asset type
- Stock
- Market cap
- $5.53B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TSX
- Currency
- CAD
Apotex Health Corp. APTX:TSX stock context
This page tracks Apotex Health Corp.'s APTX:TSX listing on TSX in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following APTX:TSX. APTX:TSX is the stock-level entry point for investors researching Apotex Health Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Apotex Health Corp. is a public company listed under the ticker APTX, operating in the Canadian market. The company has a market capitalization of approximately CAD 5.83 billion. Apotex focuses on providing healthcare solutions and is recognized for its commitment to improving patient outcomes.
Latest news from Apotex Health Corp.
Apotex Announces First Quarter 2027 Results
August 12, 2026
Apotex Receives Investment Grade Issuer Rating from Morningstar DBRS and Announces Amended & Restated Credit Agreement
July 16, 2026
Apotex to Announce First Quarter Fiscal 2027 Financial Results and Host Conference Call on August 12, 2026
July 9, 2026
Apotex expands U.S. hospital portfolio with launch of generic Infuvite® Adult and Pediatric Injection
July 8, 2026
Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals
July 1, 2026
Apotex Health Corp. earnings calls
Research Apotex Health Corp.
Apotex Health Corp. investor report
Review AI stock analysis and investor report context for APTX:TSX.
Apotex Health Corp. company profile
View the public company page for Apotex Health Corp. on 6ix.
Apotex Health Corp. news
Read company news and market updates connected to Apotex Health Corp..
Apotex Health Corp. investor events
Find investor webinars, events, and replay context for Apotex Health Corp..